These compounds may interact with:
Tyrosine-protein kinase SYK
Potentially involved in: prostate cancer; melanoma; multiple sclerosis; carcinoma; vascular dementia; type 2 diabetes mellitus; cancer; arthritis; cherubism; asthma; allergic hypersensitivity disease; systemic lupus erythematosus; primary immunodeficiency disease; chromoblastomycosis; allergic rhinitis; mesothelioma; adult high grade glioma; astrocytoma, pilocytic; diabetes mellitus; glioblastoma
Disease data sourced from Pharos.